TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis by Esmat YAGHOOBI, Saeed ABEDIAN, Omid BABANI, Maryam IZAD

Subjects: Get full text

The Role of TIM-3 in Glioblastoma Progression by Farah Ahmady, Amit Sharma, Adrian A. Achuthan, George Kannourakis, Rodney B. Luwor

Subjects: “…TIM-3…”
Get full text

IMMUNOLOGICAL ASPECTS OF CROHN’S DISEASE: A REGULATORY FUNCTION OF TIM-3/ GALECTIN-9 IN LYTH1 by Francesco Carini

Subjects: Get full text

New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome by E. V. Morozova, N. Yu. Tsvetkov, M. V. Barabanshchikova, K. S. Yurovskaya, I. S. Moiseev

Subjects: Get full text

Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression by Jialiu Luo, Cong Zhang, Deng Chen, Teding Chang, Shunyao Chen, Zhiqiang Lin, Chengla Yi, Zhao-Hui Tang

Subjects: Get full text

One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia by Zhiding Wang, Zhiding Wang, Zhiding Wang, Jinghong Chen, Mengzhen Wang, Linlin Zhang, Li Yu, Li Yu

Subjects: “…Tim-3…”
Get full text

In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding by Obdulia Rabal, Fernando Pastor, Helena Villanueva, Mario M Soldevilla, Sandra Hervas-Stubbs, Julen Oyarzabal

Subjects: Get full text

Down-Regulation of Tim-3 in Monocytes and Macrophages in Plasmodium Infection and Its Association with Parasite Clearance by Nan Hou, Ning Jiang, Yang Zou, Xianyu Piao, Shuai Liu, Shanshan Li, Qijun Chen, Qijun Chen

Subjects: Get full text

T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review by Benjamin Duong, Pratyush Banskota, Gerald S. Falchook

Subjects: “…tim-3 inhibitor…”
Get full text

Dok-3 deficient mice display different immune clustering and Tim-3 expression by Wenjiang Yan, Yijia Tian, Peng Sun, Jingjing Yang, Na Li, Yuanyuan Sun, Shuangxi Wang, Cheng Zhang

Subjects: Get full text

Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy by Catherine A. Sabatos-Peyton, James Nevin, Ansgar Brock, John D. Venable, Dewar J. Tan, Nasim Kassam, Fangmin Xu, John Taraszka, Luke Wesemann, Thomas Pertel, Nandini Acharya, Max Klapholz, Yassaman Etminan, Xiaomo Jiang, Yu-Hwa Huang, Richard S. Blumberg, Vijay K. Kuchroo, Ana C. Anderson

Subjects: Get full text

High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection by Lucero A. Ramon-Luing, Ranferi Ocaña-Guzman, Norma A. Téllez-Navarrete, Mario Preciado-García, Dámaris P. Romero-Rodríguez, Enrique Espinosa, Gustavo Reyes-Terán, Leslie Chavez-Galan

Subjects: Get full text

The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma by Melanie Wiecken, Devayani Machiraju, Shounak Chakraborty, Eva-Maria Mayr, Bénédicte Lenoir, Rosa Eurich, Jasmin Richter, Nicole Pfarr, Niels Halama, Jessica C. Hassel

Subjects: Get full text

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting by Jiaxiong Tan, Huo Tan, Yangqiu Li

Subjects: “…TIM-3…”
Get full text

Expression Of TIM-3 And CEACAM-1 In Bladder Urothelial Carcinoma ( Immunohistochmical And Histopathological Study ) by Abla Sayed Mahmoud, Sahar Ali Daoud, Wesam Ismail Moustafa, Osama Sayed, Badawia Bayoumi Ibrahim, Marwa Mohamed Sayed, Sarah Abdelrahman Mohammed

Subjects: “…tim-3…”
Get full text

T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management by Yoneda A, Jinushi M

Subjects: “…TIM-3…”
Get full text

Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation by Farah Ahmady, Peter Curpen, Louis Perriman, Adilson Fonseca Teixeira, Siqi Wu, Hong-Jian Zhu, Arpita Poddar, Aparna Jayachandran, George Kannourakis, Rodney B. Luwor

Subjects: “…TIM-3…”
Get full text

The role of TIM-3 in sepsis: a promising target for immunotherapy? by Changli Wang, Jinhai Liu, Qi Wu, Zhi Wang, Baoji Hu, Lulong Bo

Subjects: “…TIM-3…”
Get full text

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation by Kui Zang, Liangliang Hui, Min Wang, Ying Huang, Xingxing Zhu, Bin Yao

Subjects: Get full text

Tim-3 expression and its role in hepatocellular carcinoma by Feifei Liu, Yanning Liu, Zhi Chen

Subjects: Get full text